Step 1: The question pivots on which disease pairs with the anti-endomysial antibody. This antibody targets the endomysium of smooth muscle and is the serological signature of gluten sensitivity.
Step 2: Gluten triggers flattening of the small bowel villi and mucosal immune activation in coeliac disease. Because EMA testing carries very high sensitivity and specificity, it serves as an excellent screening marker, alongside tissue transglutaminase and antigliadin antibodies.
Step 3: Each distractor belongs to a different autoantibody. Myasthenia gravis links to acetylcholine receptor antibodies, autoimmune hepatitis to anti smooth muscle antibodies, and Graves disease to TSH receptor stimulating antibodies. None involve endomysium, so the answer is coeliac disease, managed by lifelong gluten avoidance.
\[\boxed{\text{Coeliac disease}}\]